Filetype
Epidemiology is the study of the distribution of diseases and disease promoting factors in the population. The cardiovascular epidemiology research group focuses on studies of cerebrovascular diseases (stroke) and heart diseases, such as myocardial infarction, heart failure or atrial fibrillation. The research is performed in well characterized population-based cohorts, with extensive information
We aim to identify novel interventions for prevention and treatment of diabetes-related cardiovascular disease (CVD). Our strategy is to identify genetic, endocrine and metabolic disturbances in humans which are causally related to disease development and are detectable many years before disease presents. We then test in both animals and in human intervention studies if manipulation of such molecu
Välkommen till Institutionen för hälsovetenskaper, en av sex institutioner vid Medicinska fakulteten, Lunds universitet. Genom vår forskning ökar vi kunskapen och förståelsen om människors hälsa och livskvalitet. Hälsofrämjande och förebyggande insatser, behandlande åtgärder, vård och omsorg och rehabilitering är centrala forskningsområden. Vi arbetar i nära samarbete med hälso- och sjukvård och kThe Department of Health Sciences is one of six departments at the Faculty of Medicine, Lund University. We conduct research within the field of health sciences. Health promotion and prevention efforts, Treatment measures, Health and social care and Rehabilitation are key research areas. We work in close collaboration with health care and municipalities to translate research results into practical
Hjärt-kärlsjukdom är världens vanligaste dödsorsak. Det främsta underliggande tillståndet är ateroskleros: plack som bildas i blodkärlens väggar och kan orsaka akuta komplikationer, såsom hjärtinfarkt och stroke. Genom vår forskning ämnar vi identifiera kliniska metoder som kan hjälpa oss att hitta plack med hög komplikationsrisk, för att i tid kunna ge adekvat förebyggande behandling. Vi vill äveCardiovascular disease is the most common cause of death. The main underlying condition is atherosclerosis: plaques formed in the arteries which can cause complications as stroke or myocardial infarction. Our research aims to prevent complications by identifying clinical methods to detect patients with high-risk plaques to personalize treatment strategies as well as novel mechanisms to use as ther
Existing metastatic disease represents a major clinical challenge. The long-term goal of our study is to gain deeper understanding of cellular mechanisms underlying cancer metastasis. We focus on identification and validation of new predictive biomarkers and drug targets that are specifically for metastatic cancer. We recently focus on studying the role of lipid kinases in particular, phosphatidyl
